QDENGA, India's first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.
The approval comes at a critical time for public health, as reported dengue cases in India have increased 11-fold in the past ...
Qdenga, cleared this week for ages 4 to 60, is one of only a few dengue vaccines in the world. It is to be injected in two ...
The government on Tuesday said Takeda Biopharmaceuticals India’s dengue vaccine, QDENGA, has been granted market ...
The government on Tuesday said Takeda Biopharmaceuticals Indias dengue vaccine, QDENGA, has been granted market authorisation ...
The health ministry said the approval was supported by evidence generated through an extensive global clinical development ...
Already approved in 42 countries and WHO-prequalified, Qdenga is expected to complement India's existing dengue prevention ...
India's CDSCO has approved the first dengue vaccine, Qdenga, for individuals aged 4 to 60 after rigorous evaluation.
The vaccine has been cleared for use in individuals aged 4 to 60 years and can be administered irrespective of whether the ...
India approves its first dengue vaccine, Qdenga, as CDSCO grants marketing authorisation to Takeda's vaccine, marking a major ...
India has approved its first vaccine for the prevention of dengue, with the Central Drugs Standard Control Organisation (CDSCO) granting marketing authorisation to Japanese drugmaker Takeda for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results